<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="pmcid: 6463034 doi: 10.3390/jcm8030369jcm-08-00369 : Opinion The Scientific Response to" exact="Zika" post="Virus https://orcid.org/0000-0001-6015-3613Martín-AcebesMiguel A.*https://orcid.org/0000-0001-8269-5544SaizJuan-Carlos[], jcsaiz@inia.es *Correspondence: martin.mangel@inia.es; Tel.: +34-91-347-8770 epub:"/>
 <result pre="of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract" exact="Zika" post="virus (ZIKV) is a mosquito-borne pathogen that became renowned"/>
 <result pre="or cause mild illnesses, in a reduced number of cases," exact="ZIKV" post="can also produce severe complications that include neurological disorders"/>
 <result pre="a significant part of the scientific community were placed on" exact="ZIKV" post="research, which has resulted in an unpredicted escalation of"/>
 <result pre="this virus. The rapid response of the scientific community against" exact="ZIKV" post="highlights its enormous potential to counter attack a viral"/>
 <result pre="ZIKV. Nevertheless, there are still other arboviral threats different from" exact="ZIKV" post="that should not be forgotten. Zika virus epidemics scientific"/>
 <result pre="arboviral threats different from ZIKV that should not be forgotten." exact="Zika" post="virus epidemics scientific literature antiviral vaccines Zika virus (ZIKV)"/>
 <result pre="not be forgotten. Zika virus epidemics scientific literature antiviral vaccines" exact="Zika" post="virus (ZIKV) is a flavivirus transmitted by mosquitoes that"/>
 <result pre="association with neonatal malformations (i.e., microcephaly) in Brazil [1]. Although" exact="ZIKV" post="is responsible for congenital Zika syndrome, most infections are"/>
 <result pre="microcephaly) in Brazil [1]. Although ZIKV is responsible for congenital" exact="Zika" post="syndrome, most infections are asymptomatic or only cause mild"/>
 <result pre="pain, malaise, or headache. In a reduced number of cases," exact="ZIKV" post="can also produce severe complications that include neurological disorders"/>
 <result pre="efforts of the scientific community were conducted to rapidly understand" exact="ZIKV" post="biology and pathology, improve diagnostic methodologies, and develop specific"/>
 <result pre="prophylactic alternatives. In fact, bibliometric analyses of the impact of" exact="ZIKV" post="on scientific literature showed a huge increment in ZIKV-related"/>
 <result pre="this can be easily and rapidly visualized by searching for" exact="Zika" post="virus or ZIKV at PubMed, which is the most"/>
 <result pre="easily and rapidly visualized by searching for Zika virus or" exact="ZIKV" post="at PubMed, which is the most commonly used engine"/>
 <result pre="were performed for other medically relevant arthropod-borne viruses (arboviruses) namely," exact="Dengue" post="virus (DENV), Yellow fever virus (YFV), West Nile virus"/>
 <result pre="other medically relevant arthropod-borne viruses (arboviruses) namely, Dengue virus (DENV)," exact="Yellow fever" post="virus (YFV), West Nile virus (WNV), and Chikungunya virus"/>
 <result pre="viruses (arboviruses) namely, Dengue virus (DENV), Yellow fever virus (YFV)," exact="West Nile" post="virus (WNV), and Chikungunya virus (CHIKV), it was observed"/>
 <result pre="(DENV), Yellow fever virus (YFV), West Nile virus (WNV), and" exact="Chikungunya" post="virus (CHIKV), it was observed that the document count"/>
 <result pre="virus (CHIKV), it was observed that the document count for" exact="ZIKV" post="over the last three years extensively surpassed them. Remarkably,"/>
 <result pre="children [9]. Thus, it could seem that the response against" exact="ZIKV" post="has been overdimensioned in comparison to other viral threats."/>
 <result pre="clear is that the interest of the research community on" exact="ZIKV" post="grew to unexpected levels after the 2015 epidemic. This"/>
 <result pre="easily exemplified by the comparison of the research results for" exact="ZIKV" post="after the Brazilian outbreak in 2015 with other recent"/>
 <result pre="2015 with other recent viral outbreaks such as that of" exact="WNV" post="in 1999 in North America [10], CHIKV in 2004–2005"/>
 <result pre="as that of WNV in 1999 in North America [10]," exact="CHIKV" post="in 2004–2005 southwestern Indian Ocean region, India, and Southeast"/>
 <result pre="and reliable serological tests has been greatly expanded after the" exact="ZIKV" post="uprising in Brazil [13]. Moreover, important milestones of ZIKV"/>
 <result pre="the ZIKV uprising in Brazil [13]. Moreover, important milestones of" exact="ZIKV" post="research were rapidly achieved. One of them was the"/>
 <result pre="amenable animal models. Although non-human primates are naturally susceptible to" exact="ZIKV" post="infection, ethical, financial, and operative concerns limited their utilization"/>
 <result pre="immuno-deficient mice solved the problems with the &quot;resistance�? to peripheral" exact="ZIKV" post="infection in adult mice and provided useful animal models"/>
 <result pre="infection in adult mice and provided useful animal models for" exact="ZIKV" post="infection [14]. These mice models have contributed to the"/>
 <result pre="culture systems (brain organoids) also contributed to the understanding of" exact="ZIKV" post="pathology [15]. On combining clinical findings, animal, organoid, and"/>
 <result pre="[16]. However, it should be highlighted that critical questions about" exact="ZIKV" post="biology and its pathogenesis are not yet fully understood"/>
 <result pre="promising approaches for the rapid identification of drugs effective against" exact="ZIKV" post="was carried out by drug repositioning studies screening libraries"/>
 <result pre="suitable for pharmacological intervention. The structure of some of the" exact="ZIKV" post="proteins has been solved, which probably accelerates both drug"/>
 <result pre="that could be effective against other medically relevant flaviviruses like" exact="DENV" post="or WNV, and could even help to combat other"/>
 <result pre="drug licensed to combat any flavivirus. Moreover, antiviral therapies against" exact="ZIKV" post="will have to face extra challenges such as safety"/>
 <result pre="Japanese encephalitis, or tick-borne-encephalitis invite optimism. However, the experience with" exact="DENV" post="vaccination indicated that vaccine performance may depends on serostatus,"/>
 <result pre="Results from animal experimentation suggest that the immunological crosstalk between" exact="ZIKV" post="and other flaviviruses (i.e., DENV) could complicate massive utilization"/>
 <result pre="that induce a generation of cross-reactive antibodies that may enhance" exact="DENV" post="infection, although there are promising approaches to minimize this"/>
 <result pre="is anecdotal evidence showing that neutralizing antibodies if induced against" exact="ZIKV" post="and DENV at high titers could potentially prevent enhancement"/>
 <result pre="evidence showing that neutralizing antibodies if induced against ZIKV and" exact="DENV" post="at high titers could potentially prevent enhancement of infection"/>
 <result pre="enhancement of infection [26,27]. Thus, in order to develop safe" exact="ZIKV" post="vaccines, an important effort is urgently required to assess"/>
 <result pre="populations suitable for ZIKV-vaccination [28]. In summary, the response against" exact="ZIKV" post="highlights the enormous potential of the scientific community to"/>
 <result pre="will have affordable and effective prophylactic and therapeutic tools against" exact="ZIKV" post="in a reasonable period of time. Nevertheless, we would"/>
 <result pre="be remembered that there are still arboviral threats other than" exact="ZIKV" post="that should not be forgotten. Author Contributions Conceptualization, M.A.M.-A."/>
 <result pre="with Microcephaly, Stillbirths, and MiscarriageJ. Clin. Med.2018749610.3390/jcm712049630487475 2.PiersonT.C.DiamondM.S.The emergence of" exact="Zika" post="virus and its new clinical syndromesNature201856057358110.1038/s41586-018-0446-y30158602 3.SaizJ.C.Martin-AcebesM.A.Bueno-MariR.SalomonO.D.Villamil-JimenezL.C.HeukelbachJ.AlencarC.H.ArmstrongP.K.Ortiga-CarvalhoT.M.Mendez-OteroR.et al.Zika Virus:"/>
 <result pre="the Recent Epidemic?Front Microbiol.20178155410.3389/fmicb.2017.0155428878742 4.KurscheidtF.A.MesquitaC.S.S.DamkeG.DamkeE.CarvalhoA.SuehiroT.T.TeixeiraJ.J.V.da SilvaV.R.S.SouzaR.P.ConsolaroM.E.L.Persistence and clinical relevance of" exact="Zika" post="virus in the male genital tractNat. Rev. Urol.201810.1038/s41585-019-0149-730696994 5.Martinez-PulgarinD.F.Acevedo-MendozaW.F.Cardona-OspinaJ.A.Rodriguez-MoralesA.J.Paniz-MondolfiA.E.A"/>
 <result pre="male genital tractNat. Rev. Urol.201810.1038/s41585-019-0149-730696994 5.Martinez-PulgarinD.F.Acevedo-MendozaW.F.Cardona-OspinaJ.A.Rodriguez-MoralesA.J.Paniz-MondolfiA.E.A bibliometric analysis of global" exact="Zika" post="researchTravel Med. Infect. Dis.201614555710.1016/j.tmaid.2015.07.00526257029 6.AlbuquerqueP.C.CastroM.J.Santos-GandelmanJ.OliveiraA.C.PeraltaJ.M.RodriguesM.L.Bibliometric Indicators of the Zika"/>
 <result pre="global Zika researchTravel Med. Infect. Dis.201614555710.1016/j.tmaid.2015.07.00526257029 6.AlbuquerqueP.C.CastroM.J.Santos-GandelmanJ.OliveiraA.C.PeraltaJ.M.RodriguesM.L.Bibliometric Indicators of the" exact="Zika" post="OutbreakPLoS Negl. Trop. Dis.201711e000513210.1371/journal.pntd.000513228103326 7.de MeloM.C.DionalisioM.R.Ribas de FreitasA.R.Zika virus,"/>
 <result pre="J. Curr. Res.2017913 8.DelwicheF.A.Bibliometric Analysis of Scholarly Publications on the" exact="Zika" post="Virus, 1952–2016Sci. Tech. Libr.20183711312910.1080/0194262X.2018.1431589 9.KatzelnickL.C.ColomaJ.HarrisE.Dengue: knowledge gaps, unmet needs,"/>
 <result pre="Ebola: the 2014 epidemicGlobal Health2016125310.1186/s12992-016-0194-427624088 13.HerradaC.A.KabirM.A.AltamiranoR.AsgharW.Advances in Diagnostic Methods for" exact="Zika" post="Virus InfectionJ. Med. Device2018120408021408021110.1115/1.404108630662580 14.NazeraiL.Pravsgaard ChristensenJ.Randrup ThomsenA.A ’Furry-Tale’ of"/>
 <result pre="Zika Virus InfectionJ. Med. Device2018120408021408021110.1115/1.404108630662580 14.NazeraiL.Pravsgaard ChristensenJ.Randrup ThomsenA.A ’Furry-Tale’ of" exact="Zika" post="Virus Infection: What Have We Learned from Animal Models?Viruses2019112910.3390/v1101002930621317"/>
 <result pre="We Learned from Animal Models?Viruses2019112910.3390/v1101002930621317 15.SutarjonoB.Can We Better Understand How" exact="Zika" post="Leads to Microcephaly? A Systematic Review of the Effects"/>
 <result pre="to Microcephaly? A Systematic Review of the Effects of the" exact="Zika" post="Virus on Human Brain OrganoidsJ. Infect. Dis.201921973474510.1093/infdis/jiy57230256965 16.WenZ.SongH.MingG.L.How does"/>
 <result pre="Zika Virus on Human Brain OrganoidsJ. Infect. Dis.201921973474510.1093/infdis/jiy57230256965 16.WenZ.SongH.MingG.L.How does" exact="Zika" post="virus cause microcephaly?Genes Dev.20173184986110.1101/gad.298216.11728566536 17.SaizJ.C.Martin-AcebesM.A.The Race To Find Antivirals"/>
 <result pre="virus cause microcephaly?Genes Dev.20173184986110.1101/gad.298216.11728566536 17.SaizJ.C.Martin-AcebesM.A.The Race To Find Antivirals for" exact="Zika" post="VirusAntimicrob. Agents Chemother.201761e00411e0041710.1128/AAC.00411-1728348160 18.HasanS.S.SevvanaM.KuhnR.J.RossmannM.G.Structural biology of Zika virus and"/>
 <result pre="Find Antivirals for Zika VirusAntimicrob. Agents Chemother.201761e00411e0041710.1128/AAC.00411-1728348160 18.HasanS.S.SevvanaM.KuhnR.J.RossmannM.G.Structural biology of" exact="Zika" post="virus and other flavivirusesNat. Struct. Mol. Biol.201825132010.1038/s41594-017-0010-829323278 19.BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents"/>
 <result pre="flavivirusesNat. Struct. Mol. Biol.201825132010.1038/s41594-017-0010-829323278 19.BoldescuV.BehnamM.A.M.VasilakisN.KleinC.D.Broad-spectrum agents for flaviviral infections: dengue," exact="Zika" post="and beyondNat. Rev. Drug. Discov.20171656558610.1038/nrd.2017.3328473729 20.SalamA.P.RojekA.DunningJ.HorbyP.W.Clinical Trials of Therapeutics"/>
 <result pre="Discov.20171656558610.1038/nrd.2017.3328473729 20.SalamA.P.RojekA.DunningJ.HorbyP.W.Clinical Trials of Therapeutics for the Prevention of Congenital" exact="Zika" post="Virus Disease: Challenges and Potential SolutionsAnn. Intern. Med.201716672573210.7326/M16-253028319995 21.DiamondM.S.LedgerwoodJ.E.PiersonT.C.Zika"/>
 <result pre="of New ChallengesAnnu. Rev. Med.20187012113510.1146/annurev-med-040717-05112730388054 22.Wilder-SmithA.OoiE.E.HorstickO.WillsB.DengueLancet201939335036310.1016/S0140-6736(18)32560-130696575 23.GeorgeJ.ValiantW.G.MattapallilM.J.WalkerM.HuangY.S.VanlandinghamD.L.MisamoreJ.GreenhouseJ.WeissD.E.VerthelyiD.et al.Prior Exposure to" exact="Zika" post="Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus MacaquesSci."/>
 <result pre="Peak Dengue-2 Viremia in Rhesus MacaquesSci. Rep.201771049810.1038/s41598-017-10901-128874759 24.FowlerA.M.TangW.W.YoungM.P.MamidiA.ViramontesK.M.McCauleyM.D.CarlinA.F.SchooleyR.T.SwanstromJ.BaricR.S.et al.Maternally Acquired" exact="Zika" post="Antibodies Enhance Dengue Disease Severity in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343"/>
 <result pre="in Rhesus MacaquesSci. Rep.201771049810.1038/s41598-017-10901-128874759 24.FowlerA.M.TangW.W.YoungM.P.MamidiA.ViramontesK.M.McCauleyM.D.CarlinA.F.SchooleyR.T.SwanstromJ.BaricR.S.et al.Maternally Acquired Zika Antibodies Enhance" exact="Dengue" post="Disease Severity in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343 25.RichnerJ.M.HimansuS.DowdK.A.ButlerS.L.SalazarV.FoxJ.M.JulanderJ.G.TangW.W.ShrestaS.PiersonT.C.et al.Modified mRNA"/>
 <result pre="in MiceCell Host Microbe20182474375010.1016/j.chom.2018.09.01530439343 25.RichnerJ.M.HimansuS.DowdK.A.ButlerS.L.SalazarV.FoxJ.M.JulanderJ.G.TangW.W.ShrestaS.PiersonT.C.et al.Modified mRNA Vaccines Protect against" exact="Zika" post="Virus InfectionCell20171681114112510.1016/j.cell.2017.02.01728222903 26.ValiantW.G.LalaniT.YunH.C.KunzA.BurgessT.H.MattapallilJ.J.Human Serum with High Neutralizing Antibody Titers"/>
 <result pre="InfectionCell20171681114112510.1016/j.cell.2017.02.01728222903 26.ValiantW.G.LalaniT.YunH.C.KunzA.BurgessT.H.MattapallilJ.J.Human Serum with High Neutralizing Antibody Titers Against Both" exact="Zika" post="and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement"/>
 <result pre="Serum with High Neutralizing Antibody Titers Against Both Zika and" exact="Dengue" post="Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of Dengue"/>
 <result pre="and Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of" exact="Dengue" post="Virus InfectionOpen Forum Infect. Dis.20185ofy15110.1093/ofid/ofy15130019003 27.ValiantW.G.HuangY.S.VanlandinghamD.L.HiggsS.LewisM.G.MattapallilJ.J.Zika convalescent macaques display"/>
 <result pre="or Phantom Menace?Front Cell Infect. Microbiol.201884410.3389/fcimb.2018.0004429497604 Figure 1 Impact of" exact="Zika" post="virus (ZIKV) on scientific literature. (A) The graph displays"/>
 <result pre="(A) The graph displays the number of search results for" exact="Zika" post="virus or ZIKV retrieved from PubMed using the &quot;Results"/>
 <result pre="displays the number of search results for Zika virus or" exact="ZIKV" post="retrieved from PubMed using the &quot;Results by year�? tool."/>
 <result pre="outbreak and 3–6 years after is compared. The outbreaks of" exact="ZIKV" post="in 2015 in South America, West Nile virus (WNV)"/>
 <result pre="compared. The outbreaks of ZIKV in 2015 in South America," exact="West Nile" post="virus (WNV) in 1999 in North America, Chikungunya virus"/>
 <result pre="America, West Nile virus (WNV) in 1999 in North America," exact="Chikungunya" post="virus (CHIKV) in 2004–2005 in the southwestern Indian Ocean"/>
</results>
